NIOBRICE Trademark

Trademark Overview


On Tuesday, October 20, 2015, a trademark application was filed for NIOBRICE with the United States Patent and Trademark Office. The USPTO has given the NIOBRICE trademark a serial number of 79178966. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, April 8, 2019. This trademark is owned by Novartis AG. The NIOBRICE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-inf...
niobrice

General Information


Serial Number79178966
Word MarkNIOBRICE
Filing DateTuesday, October 20, 2015
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, April 8, 2019
Registration Number4958024
Registration DateTuesday, May 17, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 1, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateTuesday, March 12, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Sunday, July 17, 2022NOTIFICATION PROCESSED BY IB
Tuesday, April 27, 2021CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Saturday, April 24, 2021CORRECTION TRANSACTION RECEIVED FROM IB
Saturday, November 2, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Saturday, November 2, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, March 29, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, March 29, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, November 18, 2016NOTIFICATION PROCESSED BY IB
Friday, June 17, 2016FINAL DISPOSITION NOTICE SENT TO IB
Friday, June 17, 2016FINAL DISPOSITION PROCESSED
Thursday, June 16, 2016GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, May 17, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, March 1, 2016PUBLISHED FOR OPPOSITION
Friday, February 26, 2016NOTIFICATION PROCESSED BY IB
Wednesday, February 10, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 10, 2016NOTICE OF PUBLICATION
Wednesday, February 10, 2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, January 19, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 12, 2016ASSIGNED TO EXAMINER
Friday, January 1, 2016APPLICATION FILING RECEIPT MAILED
Monday, December 28, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 18, 2015LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, December 17, 2015SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB